LymphedemaV1, PascalFrancis, Curation, bibRecord, 000289

Lymphoscintigraphic analysis in chromoblastomycosis

Identifieur interne : 000289 ( PascalFrancis/Curation ); précédent : 000288; suivant : 000290

Lymphoscintigraphic analysis in chromoblastomycosis

Auteurs : Marilia M. Ogawa [Brésil] ; Mauricio M. A. Alchorne ; Antonio Barbieri ; Mario L. V. Castiglioni ; Adriana Porto Benatti Penna ; Jane Tomimori-Yamashita

Source :

International journal of dermatology [ 0011-9059 ] ; 2003.

RBID : Pascal:03-0501918

Descripteurs français

Pascal (Inist)
- Chromoblastomycose, Homme, Brésil, Scintigraphie, Système lymphatique, Lymphoedème, Diagnostic.
Wicri :
- geographic : Brésil.
- topic : Homme.

English descriptors

KwdEn :
- Brazil, Chromoblastomycosis, Diagnosis, Human, Lymphatic system, Lymphedema, Scintigraphy.

Abstract

Background One of the main complications of chromoblastomycosis is lymphedema. The purpose of this study was to evaluate the lymphatic system of the limbs of patients with chromoblastomycosis using lymphoscintigraphy. It is a reliable, objective and noninvasive means of supporting the diagnosis of lymphedema. Methods Lymphoscintigraphy was performed in seven patients with chromoblastomycosis, six with lesions in the lower limb and one in the upper limb. Tc-99 m dextran was injected into the interdigital spaces of the upper or lower extremities. The qualitative parameters analyzed were the visibilization of the lymph vessels and the lymph nodes, dermal backflow, and existence of collateral vessels. All patients were treated with the association of itraconazole and cryotherapy with liquid nitrogen. Results Three out of the 14 extremities examined had lymphedema clinically, and the lymphoscintigraphy showed abnormalities in the qualitative parameters; whereas these parameters were normal in the extremities without lymphedema. During the treatment of chromoblastomycosis, a second lymphoscintigraphy exam was performed on 10 limbs and did not show any improvement of the previous lymphoscintigraphic alterations. Conclusions The qualitative lymphoscintigraphy was a reliable method to show the morphology of the lymph vessels and confirm objectively the diagnosis of lymphedema secondary to chromoblastomycosis. The association of oral itraconazol and cryotherapy did not modify the lymphatic alterations in chromoblastomycosis.

A01	`01`	`1`		`@0 0011-9059`
A02	`01`			`@0 IJDEBB`
A03		`1`		`@0 Int. j. dermatol.`
A05				`@2 42`
A06				`@2 8`
A08	`01`	`1`	`ENG`	`@1 Lymphoscintigraphic analysis in chromoblastomycosis`
A11	`01`	`1`		`@1 OGAWA (Marilia M.)`
A11	`02`	`1`		`@1 ALCHORNE (Mauricio M. A.)`
A11	`03`	`1`		`@1 BARBIERI (Antonio)`
A11	`04`	`1`		`@1 CASTIGLIONI (Mario L. V.)`
A11	`05`	`1`		`@1 PORTO BENATTI PENNA (Adriana)`
A11	`06`	`1`		`@1 TOMIMORI-YAMASHITA (Jane)`
A14	`01`			`@1 Departments of Dermatology and Nuclear Medicine, Federal University of Sao Paulo @3 BRA`
A20				`@1 622-625`
A21				`@1 2003`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 11580 @5 354000112313970080`
A44				`@0 0000 @1 © 2003 INIST-CNRS. All rights reserved.`
A45				`@0 10 ref.`
A47	`01`	`1`		`@0 03-0501918`
A60				`@1 P @3 C`
A61				`@0 A`
A64	`01`	`1`		`@0 International journal of dermatology`
A66	`01`			`@0 GBR`
C01	`01`		`ENG`	@0 Background One of the main complications of chromoblastomycosis is lymphedema. The purpose of this study was to evaluate the lymphatic system of the limbs of patients with chromoblastomycosis using lymphoscintigraphy. It is a reliable, objective and noninvasive means of supporting the diagnosis of lymphedema. Methods Lymphoscintigraphy was performed in seven patients with chromoblastomycosis, six with lesions in the lower limb and one in the upper limb. Tc-99 m dextran was injected into the interdigital spaces of the upper or lower extremities. The qualitative parameters analyzed were the visibilization of the lymph vessels and the lymph nodes, dermal backflow, and existence of collateral vessels. All patients were treated with the association of itraconazole and cryotherapy with liquid nitrogen. Results Three out of the 14 extremities examined had lymphedema clinically, and the lymphoscintigraphy showed abnormalities in the qualitative parameters; whereas these parameters were normal in the extremities without lymphedema. During the treatment of chromoblastomycosis, a second lymphoscintigraphy exam was performed on 10 limbs and did not show any improvement of the previous lymphoscintigraphic alterations. Conclusions The qualitative lymphoscintigraphy was a reliable method to show the morphology of the lymph vessels and confirm objectively the diagnosis of lymphedema secondary to chromoblastomycosis. The association of oral itraconazol and cryotherapy did not modify the lymphatic alterations in chromoblastomycosis.
C02	`01`	`X`		`@0 002B05D02K2`
C02	`02`	`X`		`@0 235`
C03	`01`	`X`	`FRE`	`@0 Chromoblastomycose @5 01`
C03	`01`	`X`	`ENG`	`@0 Chromoblastomycosis @5 01`
C03	`01`	`X`	`SPA`	`@0 Cromoblastomicosis @5 01`
C03	`02`	`X`	`FRE`	`@0 Homme @5 02`
C03	`02`	`X`	`ENG`	`@0 Human @5 02`
C03	`02`	`X`	`SPA`	`@0 Hombre @5 02`
C03	`03`	`X`	`FRE`	`@0 Brésil @2 NG @5 03`
C03	`03`	`X`	`ENG`	`@0 Brazil @2 NG @5 03`
C03	`03`	`X`	`SPA`	`@0 Brasil @2 NG @5 03`
C03	`04`	`X`	`FRE`	`@0 Scintigraphie @5 04`
C03	`04`	`X`	`ENG`	`@0 Scintigraphy @5 04`
C03	`04`	`X`	`SPA`	`@0 Centelleografía @5 04`
C03	`05`	`X`	`FRE`	`@0 Système lymphatique @5 05`
C03	`05`	`X`	`ENG`	`@0 Lymphatic system @5 05`
C03	`05`	`X`	`SPA`	`@0 Sistema linfático @5 05`
C03	`06`	`X`	`FRE`	`@0 Lymphoedème @5 07`
C03	`06`	`X`	`ENG`	`@0 Lymphedema @5 07`
C03	`06`	`X`	`SPA`	`@0 Linfedema @5 07`
C03	`07`	`X`	`FRE`	`@0 Diagnostic @5 08`
C03	`07`	`X`	`ENG`	`@0 Diagnosis @5 08`
C03	`07`	`X`	`SPA`	`@0 Diagnóstico @5 08`
C07	`01`	`X`	`FRE`	`@0 Mycose`
C07	`01`	`X`	`ENG`	`@0 Mycosis`
C07	`01`	`X`	`SPA`	`@0 Micosis`
C07	`02`	`X`	`FRE`	`@0 Infection`
C07	`02`	`X`	`ENG`	`@0 Infection`
C07	`02`	`X`	`SPA`	`@0 Infección`
C07	`03`	`X`	`FRE`	`@0 Amérique du Sud @2 NG`
C07	`03`	`X`	`ENG`	`@0 South America @2 NG`
C07	`03`	`X`	`SPA`	`@0 America del sur @2 NG`
C07	`04`	`X`	`FRE`	`@0 Amérique @2 NG`
C07	`04`	`X`	`ENG`	`@0 America @2 NG`
C07	`04`	`X`	`SPA`	`@0 America @2 NG`
C07	`05`	`X`	`FRE`	`@0 Exploration radioisotopique @5 45`
C07	`05`	`X`	`ENG`	`@0 Radionuclide study @5 45`
C07	`05`	`X`	`SPA`	`@0 Exploración radioisotópica @5 45`
C07	`06`	`X`	`FRE`	`@0 Imagerie médicale @5 46`
C07	`06`	`X`	`ENG`	`@0 Medical imagery @5 46`
C07	`06`	`X`	`SPA`	`@0 Imaginería médica @5 46`
C07	`07`	`X`	`FRE`	`@0 Appareil circulatoire pathologie @5 53`
C07	`07`	`X`	`ENG`	`@0 Cardiovascular disease @5 53`
C07	`07`	`X`	`SPA`	`@0 Aparato circulatorio patología @5 53`
C07	`08`	`X`	`FRE`	`@0 Lymphatique pathologie @5 54`
C07	`08`	`X`	`ENG`	`@0 Lymphatic vessel disease @5 54`
C07	`08`	`X`	`SPA`	`@0 Linfático patología @5 54`
C07	`09`	`X`	`FRE`	`@0 Peau pathologie @5 70`
C07	`09`	`X`	`ENG`	`@0 Skin disease @5 70`
C07	`09`	`X`	`SPA`	`@0 Piel patología @5 70`
N21				`@1 335`
N82				`@1 PSI`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000671

Links to Exploration step

Pascal:03-0501918

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Lymphoscintigraphic analysis in chromoblastomycosis</title>
<author><name sortKey="Ogawa, Marilia M" sort="Ogawa, Marilia M" uniqKey="Ogawa M" first="Marilia M." last="Ogawa">Marilia M. Ogawa</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Departments of Dermatology and Nuclear Medicine, Federal University of Sao Paulo</s1>
<s3>BRA</s3>
</inist:fA14>
<country>Brésil</country>
</affiliation>
</author>
<author><name sortKey="Alchorne, Mauricio M A" sort="Alchorne, Mauricio M A" uniqKey="Alchorne M" first="Mauricio M. A." last="Alchorne">Mauricio M. A. Alchorne</name>
</author>
<author><name sortKey="Barbieri, Antonio" sort="Barbieri, Antonio" uniqKey="Barbieri A" first="Antonio" last="Barbieri">Antonio Barbieri</name>
</author>
<author><name sortKey="Castiglioni, Mario L V" sort="Castiglioni, Mario L V" uniqKey="Castiglioni M" first="Mario L. V." last="Castiglioni">Mario L. V. Castiglioni</name>
</author>
<author><name sortKey="Porto Benatti Penna, Adriana" sort="Porto Benatti Penna, Adriana" uniqKey="Porto Benatti Penna A" first="Adriana" last="Porto Benatti Penna">Adriana Porto Benatti Penna</name>
</author>
<author><name sortKey="Tomimori Yamashita, Jane" sort="Tomimori Yamashita, Jane" uniqKey="Tomimori Yamashita J" first="Jane" last="Tomimori-Yamashita">Jane Tomimori-Yamashita</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">03-0501918</idno>
<date when="2003">2003</date>
<idno type="stanalyst">PASCAL 03-0501918 INIST</idno>
<idno type="RBID">Pascal:03-0501918</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000671</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000289</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Lymphoscintigraphic analysis in chromoblastomycosis</title>
<author><name sortKey="Ogawa, Marilia M" sort="Ogawa, Marilia M" uniqKey="Ogawa M" first="Marilia M." last="Ogawa">Marilia M. Ogawa</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Departments of Dermatology and Nuclear Medicine, Federal University of Sao Paulo</s1>
<s3>BRA</s3>
</inist:fA14>
<country>Brésil</country>
</affiliation>
</author>
<author><name sortKey="Alchorne, Mauricio M A" sort="Alchorne, Mauricio M A" uniqKey="Alchorne M" first="Mauricio M. A." last="Alchorne">Mauricio M. A. Alchorne</name>
</author>
<author><name sortKey="Barbieri, Antonio" sort="Barbieri, Antonio" uniqKey="Barbieri A" first="Antonio" last="Barbieri">Antonio Barbieri</name>
</author>
<author><name sortKey="Castiglioni, Mario L V" sort="Castiglioni, Mario L V" uniqKey="Castiglioni M" first="Mario L. V." last="Castiglioni">Mario L. V. Castiglioni</name>
</author>
<author><name sortKey="Porto Benatti Penna, Adriana" sort="Porto Benatti Penna, Adriana" uniqKey="Porto Benatti Penna A" first="Adriana" last="Porto Benatti Penna">Adriana Porto Benatti Penna</name>
</author>
<author><name sortKey="Tomimori Yamashita, Jane" sort="Tomimori Yamashita, Jane" uniqKey="Tomimori Yamashita J" first="Jane" last="Tomimori-Yamashita">Jane Tomimori-Yamashita</name>
</author>
</analytic>
<series><title level="j" type="main">International journal of dermatology</title>
<title level="j" type="abbreviated">Int. j. dermatol.</title>
<idno type="ISSN">0011-9059</idno>
<imprint><date when="2003">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">International journal of dermatology</title>
<title level="j" type="abbreviated">Int. j. dermatol.</title>
<idno type="ISSN">0011-9059</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Brazil</term>
<term>Chromoblastomycosis</term>
<term>Diagnosis</term>
<term>Human</term>
<term>Lymphatic system</term>
<term>Lymphedema</term>
<term>Scintigraphy</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Chromoblastomycose</term>
<term>Homme</term>
<term>Brésil</term>
<term>Scintigraphie</term>
<term>Système lymphatique</term>
<term>Lymphoedème</term>
<term>Diagnostic</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Brésil</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background One of the main complications of chromoblastomycosis is lymphedema. The purpose of this study was to evaluate the lymphatic system of the limbs of patients with chromoblastomycosis using lymphoscintigraphy. It is a reliable, objective and noninvasive means of supporting the diagnosis of lymphedema. Methods Lymphoscintigraphy was performed in seven patients with chromoblastomycosis, six with lesions in the lower limb and one in the upper limb. Tc-99 m dextran was injected into the interdigital spaces of the upper or lower extremities. The qualitative parameters analyzed were the visibilization of the lymph vessels and the lymph nodes, dermal backflow, and existence of collateral vessels. All patients were treated with the association of itraconazole and cryotherapy with liquid nitrogen. Results Three out of the 14 extremities examined had lymphedema clinically, and the lymphoscintigraphy showed abnormalities in the qualitative parameters; whereas these parameters were normal in the extremities without lymphedema. During the treatment of chromoblastomycosis, a second lymphoscintigraphy exam was performed on 10 limbs and did not show any improvement of the previous lymphoscintigraphic alterations. Conclusions The qualitative lymphoscintigraphy was a reliable method to show the morphology of the lymph vessels and confirm objectively the diagnosis of lymphedema secondary to chromoblastomycosis. The association of oral itraconazol and cryotherapy did not modify the lymphatic alterations in chromoblastomycosis.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0011-9059</s0>
</fA01>
<fA02 i1="01"><s0>IJDEBB</s0>
</fA02>
<fA03 i2="1"><s0>Int. j. dermatol.</s0>
</fA03>
<fA05><s2>42</s2>
</fA05>
<fA06><s2>8</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Lymphoscintigraphic analysis in chromoblastomycosis</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>OGAWA (Marilia M.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>ALCHORNE (Mauricio M. A.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>BARBIERI (Antonio)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>CASTIGLIONI (Mario L. V.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>PORTO BENATTI PENNA (Adriana)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>TOMIMORI-YAMASHITA (Jane)</s1>
</fA11>
<fA14 i1="01"><s1>Departments of Dermatology and Nuclear Medicine, Federal University of Sao Paulo</s1>
<s3>BRA</s3>
</fA14>
<fA20><s1>622-625</s1>
</fA20>
<fA21><s1>2003</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>11580</s2>
<s5>354000112313970080</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2003 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>10 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>03-0501918</s0>
</fA47>
<fA60><s1>P</s1>
<s3>C</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>International journal of dermatology</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Background One of the main complications of chromoblastomycosis is lymphedema. The purpose of this study was to evaluate the lymphatic system of the limbs of patients with chromoblastomycosis using lymphoscintigraphy. It is a reliable, objective and noninvasive means of supporting the diagnosis of lymphedema. Methods Lymphoscintigraphy was performed in seven patients with chromoblastomycosis, six with lesions in the lower limb and one in the upper limb. Tc-99 m dextran was injected into the interdigital spaces of the upper or lower extremities. The qualitative parameters analyzed were the visibilization of the lymph vessels and the lymph nodes, dermal backflow, and existence of collateral vessels. All patients were treated with the association of itraconazole and cryotherapy with liquid nitrogen. Results Three out of the 14 extremities examined had lymphedema clinically, and the lymphoscintigraphy showed abnormalities in the qualitative parameters; whereas these parameters were normal in the extremities without lymphedema. During the treatment of chromoblastomycosis, a second lymphoscintigraphy exam was performed on 10 limbs and did not show any improvement of the previous lymphoscintigraphic alterations. Conclusions The qualitative lymphoscintigraphy was a reliable method to show the morphology of the lymph vessels and confirm objectively the diagnosis of lymphedema secondary to chromoblastomycosis. The association of oral itraconazol and cryotherapy did not modify the lymphatic alterations in chromoblastomycosis.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B05D02K2</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>235</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Chromoblastomycose</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Chromoblastomycosis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Cromoblastomicosis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Homme</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Human</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Hombre</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Brésil</s0>
<s2>NG</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Brazil</s0>
<s2>NG</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Brasil</s0>
<s2>NG</s2>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Scintigraphie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Scintigraphy</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Centelleografía</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Système lymphatique</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Lymphatic system</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Sistema linfático</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Lymphoedème</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Lymphedema</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Linfedema</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Diagnostic</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Diagnosis</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Diagnóstico</s0>
<s5>08</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Mycose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Mycosis</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Micosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Amérique du Sud</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>South America</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>America del sur</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Amérique</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>America</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>America</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Exploration radioisotopique</s0>
<s5>45</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Radionuclide study</s0>
<s5>45</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Exploración radioisotópica</s0>
<s5>45</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Imagerie médicale</s0>
<s5>46</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Medical imagery</s0>
<s5>46</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Imaginería médica</s0>
<s5>46</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Appareil circulatoire pathologie</s0>
<s5>53</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>53</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>53</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Lymphatique pathologie</s0>
<s5>54</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Lymphatic vessel disease</s0>
<s5>54</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Linfático patología</s0>
<s5>54</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Peau pathologie</s0>
<s5>70</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Skin disease</s0>
<s5>70</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Piel patología</s0>
<s5>70</s5>
</fC07>
<fN21><s1>335</s1>
</fN21>
<fN82><s1>PSI</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000289 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000289 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:03-0501918
   |texte=   Lymphoscintigraphic analysis in chromoblastomycosis
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Lymphoscintigraphic analysis in chromoblastomycosis

Lymphoscintigraphic analysis in chromoblastomycosis

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri